Soleus Capital Management’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-226,941
| Closed | -$479K | – | 104 |
|
|
2023
Q3 | $479K | Hold |
226,941
| – | – | 0.04% | 88 |
|
|
2023
Q2 | $595K | Hold |
226,941
| – | – | 0.07% | 93 |
|
|
2023
Q1 | $719K | Hold |
226,941
| – | – | 0.07% | 73 |
|
|
2022
Q4 | $610K | Sell |
226,941
-226,719
| -50% | -$610K | 0.09% | 67 |
|
|
2022
Q3 | $1.32M | Hold |
453,660
| – | – | 0.18% | 66 |
|
|
2022
Q2 | $1.33M | Sell |
453,660
-23,835
| -5% | -$69.6K | 0.21% | 64 |
|
|
2022
Q1 | $3.38M | Hold |
477,495
| – | – | 0.44% | 46 |
|
|
2021
Q4 | $7.64M | Buy |
+477,495
| New | +$7.64M | 0.76% | 28 |
|